Results 201 to 210 of about 14,298 (222)

GD2-KLH Vaccine

2020
openaire   +1 more source

GD2 expression is closely associated with neuronal differentiation of human umbilical cord blood-derived mesenchymal stem cells

Cellular and Molecular Life Sciences, 2010
Hye Jin Jin, Seong Who Kim, Yoon Sun Yang Yang   +2 more
exaly  

Pathogenesis of the neurotoxicity caused by anti-GD2 antibody therapy

Journal of the Neurological Sciences, 1997
N Yuki, Y Tagawa
exaly  

Ganglioside GD2 as a therapeutic target for antibody‐mediated therapy in patients with osteosarcoma

Cancer, 2014
Jonathan Gill, Richard Gorlick, Michael Roth   +2 more
exaly  

Combined sialic acid and histone deacetylase (HDAC) inhibitor treatment up-regulates the neuroblastoma antigen GD2

Journal of Biological Chemistry, 2019
Dirk J Lefeber, Christian Bull, Thomas Boltje   +2 more
exaly  

Vaccination with anti-idiotype antibody ganglidiomab mediates a GD2-specific anti-neuroblastoma immune response

Cancer Immunology, Immunotherapy, 2013
Christiane A Helm, Nikolai Siebert, Holger Lode   +2 more
exaly  

PROCESS FOR PREPARING GD2 GANGLIOSIDE AND O-ACETYL-GD2 GANGLIOSIDE

1994
KORDOWICZ MARIA, AVEMARIE NORBERT
openaire   +1 more source

GD2-Targeted Immunotherapy of Neuroblastoma

2019
Jung-Tung Hung, Alice L. Yu
openaire   +1 more source

GD2-targeting therapy: a comparative analysis of approaches and promising directions

Frontiers in Immunology
Sergey Sennikov, Julia Shevchenko
exaly  

GD2 targeting CAR T cells for neuroblastoma

EJC Paediatric Oncology
Giuseppe Barone
exaly